Gout Resource Center
Earlier this year, the ACR released a new guideline for the management of gout, leaving some rheumatologists unsure what to recommend to their patients. Clearing up the confusion is one aim of the session, Evidence-Based Guidance for Optimizing Gout Management. Learn what the experts recommend and explore our coverage of additional gout information presented at ACR Convergence 2020, plus our collection of research reviews, case reports and clinical articles on advances in the diagnosis and management of gout.
VIEW
Updates on ACR Gout Guideline, FDA’s Febuxostat Warning & Pegloticase Therapy
Gout Research at a Glance: ‘My picks for the top research in gout presented at ACR Convergence 2021’
Case Report: Does Young Woman with Gitelman Syndrome Have Gout?
Pegloticase Safe & Effective for Patients with Gout on Dialysis
Reducing Immunogenicity of Pegloticase (RECIPE) with Concomitant Use of Mycophenolate Mofetil in Patients with Refractory Gout—a Phase II Double Blind Randomized Controlled Trial
Dr. Ethan Craig Picks His Favorite Gout Abstracts from ACR Convergence 2020
Optimize Gout Management with the Latest Evidence-Based Guidance
FAST Results for Febuxostat Safety in Patients with Gout
High Opioid Prescription Rates Seen in Emergency Department-Treated Gout
- 1
- 2
- 3
- …
- 12
- Next Page »